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 Re: Association Between Biallelic 
and Monoallelic Germline MYH 
Gene Mutations and Colorectal 
Cancer Risk 
 We read with interest the paper by 
Croitoru et al.  ( 1 ) , in which they examined 
the role of germline MYH gene mutations 
in colorectal cancer and proposed an 
 autosomal dominant weakly penetrant 
mode of inheritance. Previous evidence 
has suggested a recessive mode of inheri-
tance for colorectal polyposis  ( 2 ) . Hence, 
the novel proposal by Croitoru et al. 
would be of major clinical and scientifi c 
importance and must be fully justifi ed by 
the data. We have major concerns about 
their fi ndings and respectfully refute their 
interpretation of their data. 
 The authors compared case patients 
and control subjects with no MYH gene 
mutations (genotype Wt/Wt) with case 
patients and control subjects with either 
one (genotype Wt/Mut) or two (genotype 
Mut/Mut) MYH gene mutations. How-
ever, the authors’ data do not support a 
dominant mode of inheritance. Individu-
als with a Wt/Mut genotype had no statis-
tically signifi cant excess colorectal cancer 
risk compared with those with a Wt/Wt 
genotype (odds  ratio = 1.4; 95% confi -
dence interval = 0.8 to 2.5)  ( 1 ) . Therefore, 
the authors’ decision to pool Wt/Mut indi-
viduals with homozygous Mut/Mut case 
patients for their analyses is not justifi ed. 
 Table 1 summarizes the authors’ data from 
 Table 1  ( 1 ) . We used these data and Fish-
er’s exact test to examine associations be-
tween the frequency of germline MYH 
gene mutations and colorectal cancer risk 
among case patients and control subjects 
with different MYH genotypes. Our re-
sults — P = .25 for Wt/Wt versus Wt/Mut, 
 P = 2.1 × 10 − 4  for Wt/Wt versus Mut/Mut, 
and  P = 5.3 × 10 − 3  for Wt/Mut versus 
Mut/Mut — suggest that only a recessive 
model of inheritance is tenable. Thus, the 
only valid pooling strategy supported by 
the authors’ data is to pool individuals 
with Wt/Mut and Wt/Wt genotypes (i.e., 
assume a recessive mode of inheritance). 
 Croitoru et al.  ( 1 ) also compared the 
number of affected fi rst- and  second-
 degree relatives of heterozygous and ho-
mozygous MYH gene mutation carriers 
with that of noncarriers. This approach 
does not test whether people who inherit 
one mutant allele are at equivalent risk to 
those who inherit two mutant alleles. 
The modest effects detected by the au-
thors that they ascribe to a dominant 
 effect are no more consistent with a 
dominant than a recessive mode of in-
heritance. In fact, the offspring of Wt/
Mut case patients have an increased risk 
of disease compared with offspring of 
Wt/Wt case  patients under both fully 
dominant and fully recessive modes of 
inheritance. Thus, this evidence in itself 
does not support a dominant mode of 
 inheritance. 
 Croitoru et al.  ( 1 ) also presented loss 
of heterozygosity (LOH) data for tumors 
from Wt/Mut and Mut/Mut case  patients. 
 Table 1.  Summary of data in Table 1 of Croitoru 
et al.  ( 1 ) * 
  MYH genotype  
  Wt/Wt  Wt/Mut  Mut/Mut  Total 
 Case   1197  29  12  1238 
 patients
 Control   1234  21  0  1255 
 subjects 
 Total  2431  50  12  2493 
 * MYH = MutY human homologue gene; Wt = 
wild type; Mut = mutant. 
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However, LOH at chromosome 1p in tu-
mors is highly variable and subject to 
confounding. Thorstensen et al.  ( 3 ) de-
tected LOH in chromosome 1p in 50% 
of primary carcinomas, 33% of local re-
currences, and 64% of metastases from 
colorectal cancer patients, whereas 
Ogunbiyi et al.  ( 4 ) and Zhou et al.  ( 5 ) 
detected LOH in chromosome 1p in 
26% and 22% of colorectal cancers, re-
spectively. Rashid et al.  ( 6 ) found that 
LOH in chromosome 1p varied with the 
anatomic location of hyperplastic pol-
yps. Given such variability and the small 
numbers presented by Croitoru et al. and 
the fact that their samples were not 
matched for confounding variables, the 
difference in LOH frequency at chromo-
some 1p is best explained by chance. 
 ALBERT  TENESA 
 SUSAN M.  FARRINGTON 
 MALCOLM G.  DUNLOP 
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 RE S PO N SE  ESPONSE 
 Dominant and recessive transmission 
applies to traits or phenotypes and not to 
genes themselves. A good example of 
this terminology is sickle cell disease: 
 homozygous carriers have the  disease and 
heterozygous carriers have the sickle cell 
 trait , a milder phenotype of the  disease 
 ( 1 , 2 ) . It is, of course, true that published 
reports to date clearly support a recessive 
mode of inheritance for MYH-associated 
polyposis, a phenotype associated with 
biallelic mutations in MYH  ( 3 , 4 ) . We de-
cided a priori to examine the incidence of 
MYH gene mutations as a way to vali-
date the association between biallelic 
MYH gene mutations and colorectal 
 cancer risk in a large North American 
population-based case – control series and 
to analyze the risk of colorectal cancer 
 associated with the heterozygous state. 
 Although Tenesa et al. used Fisher’s 
exact test to demonstrate, as have we, 
that biallelic mutations were more com-
mon in the colorectal cancer case patients 
than in the control subjects, their results 
failed to adequately support their argu-
ment that heterozygous carriers had no 
increased risk of colorectal cancer. We 
found a non – statistically signifi cant in-
creased risk of colorectal cancer among 
MYH heterozygotes (odds ratio = 1.4; 
95% confi dence interval = 0.8 to 2.5)  ( 5 ) . 
However, our study was inadequately 
powered to rule out this level of risk. Fur-
thermore, by using the pooled cumulative 
MYH genotype data available from the 
literature, we demonstrated a convincing 
association between mild increased 
colorectal cancer risk and heterozygous 
MYH mutations, and although this ob-
servation has now been corroborated by 
another group  ( 6 ) , the need for larger 
studies to address this issue is obvious. 
 Our results suggested a statistically 
signifi cant increased risk of colorectal 
cancer in fi rst- and second-degree family 
members of both monoallelic MYH 
 mutation carriers and in all mutation 
 carriers. We disagree with Tenesa et al., 
who suggest that a purely recessive model 
is the only possible explanation for this 
result and continue to assert that the re-
sult we obtained by Poisson regression 
(relative risk = 1.57, 95% confi dence in-
terval = 1.05 to 2.36) provides additional 
 evidence for increased colorectal cancer 
risk in monoallelic carriers. Given the 
frequency of MYH mutations in the 
 general population and in the absence of 
consanguinity, we feel we can safely as-
sume that the observed increased risk in 
family members is due to monoallelic 
carriers of the mutation present in the 
proband. Similarly, for biallelic carriers, 
25% of siblings of the proband would be 
expected to carry biallelic mutations, 
whereas 50% of siblings as well as other 
fi rst-degree relatives would be expected 
to carry monoallelic mutations. Thus, 
the magnitude of this association is too 
strong to be fully explained by a purely 
recessive model, and the increased risk 
must be due to monoallelic carriers. 
 The purpose of our loss of heterozy-
gosity (LOH) experiments was to exam-
ine whether the modest increased risk of 
colorectal cancer in heterozygous MYH 
mutation carriers was consistent with 
Knudson’s  “ two-hit ” tumorigenesis  model 
 ( 7 ) . We agree with Tenesa et al. about the 
variability of published allelotype data, 
not only for chromosome 1p, but for many 
chromosomal loci in many  tumor types. 
We confi rmed our microsatellite marker 
LOH results by analyzing the autoradio-
graphic densities corresponding to wild-
type and mutant nucleotides (data not 
shown) and found no  internal variability 
in our results. 
 The critical difference between dif-
ferent modes of inheritance relies on 
 whether a phenotype is present in hetero-
zygous carriers. In conclusion, our MYH 
gene mutation case – control frequency 
data, results of Poisson regression analy-
ses, and LOH data and phenotypic ob-
servations, as well as results of pooled 
analyses by us and by Peterlongo et al. 
 ( 6 ) , suggest that an increased risk of 
colorectal cancer conferred by the het-
erozygous state cannot be ruled out. 
 Homozygous MYH gene mutation carri-
ers are obviously at much greater risk for 
colorectal cancer than heterozygotes 
and, as we state in our article, studies 
with larger sample sizes are  clearly nec-
essary to accurately quantify risk of 
colorectal cancer in heterozygotes. 
 SEAN P.  CLEARY 
 MARINA E.  CROITORU 
 ROBERT  GRYFE 
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 MICHELLE  COTTERCHIO 
 JULIA  KNIGHT 
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